Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

ICL-670 effective in treating iron overload

Dec. 16, 2004

Aerosolized Radilex superior to muscle injection following radiation exposure

Dec. 15, 2004

Buprenorphine analogue inhibits morphine-induced behavioral sensitization in mice

Dec. 10, 2004

RiVax, first ricin vaccine to enter human clinical trials

Dec. 2, 2004

Tetrodin studied in phase II trial of opiate-dependent subjects

Nov. 18, 2004

Lobeline enters clinical trials for methamphetamine addiction

Oct. 29, 2004

Nociceptin opioid receptor antagonist may be useful in the management of addictive disorders

Oct. 27, 2004

New mGluR5 antagonists prepared and tested at Addex

Oct. 26, 2004

Topiramate as a novel approach to alcoholism

Oct. 19, 2004

Promising clinical results reported for NicVAX in smoking cessation

Oct. 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...